Ameriprise’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.17M | Buy |
|
|||||
|
2025
Q2 | $3.97M | Buy |
|
|||||
|
2025
Q1 | $699K | Buy |
|
|||||
|
2024
Q4 | $564K | Buy |
|
|||||
|
2024
Q3 | $686K | Buy |
|
|||||
|
2024
Q2 | $484K | Sell |
|
|||||
|
2024
Q1 | $638K | Buy |
|
|||||
|
2023
Q4 | $530K | Sell |
|
|||||
|
2023
Q3 | $552K | Sell |
|
|||||
|
2023
Q2 | $956K | Sell |
|
|||||
|
2023
Q1 | $2.35M | Buy |
|
|||||
|
2022
Q4 | $1.77M | Buy |
|
|||||
|
2022
Q3 | $667K | Buy |
|
|||||
|
2022
Q2 | $870K | Buy |
|
|||||
|
2022
Q1 | $1.06M | Sell |
|
|||||
|
2021
Q4 | $1.25M | Buy |
|
|||||
|
2021
Q3 | $1.33M | Sell |
|
|||||
|
2021
Q2 | $2.39M | Buy |
|
|||||
|
2021
Q1 | $2.75M | Sell |
|
|||||
|
2020
Q4 | $5.67M | Buy |
|
|||||
|
2020
Q3 | $1.91M | Buy |
|
|||||
|
2020
Q2 | $1.54M | Sell |
|
|||||
|
2020
Q1 | $1.16M | Buy |
|
|||||
|
2019
Q4 | $402K | Sell |
|
|||||
|
2019
Q3 | $38.6M | Sell |
|
|||||
|
2019
Q2 | $58.3M | Buy |
|
|||||
|
2019
Q1 | $57.4M | Sell |
|
|||||
|
2018
Q4 | $36.8M | Sell |
|
|||||
|
2018
Q3 | $94.1M | Sell |
|
|||||
|
2018
Q2 | $102M | Buy |
|
|||||
|
2018
Q1 | $61.1M | Buy |
|
|||||
|
2017
Q4 | $1.72M | Sell |
|
|||||
|
2017
Q3 | $2.48M | Sell |
|
|||||
|
2017
Q2 | $6.32M | Buy |
|
|||||
|
2017
Q1 | $6.41M | Sell |
|
|||||
|
2016
Q4 | $7.6M | Sell |
|
|||||
|
2016
Q3 | $12.3M | Sell |
|
|||||
|
2016
Q2 | $17.1M | Buy |
|
|||||
|
2016
Q1 | $13.3M | Sell |
|
|||||
|
2015
Q4 | $52.8M | Buy |
|
|||||
|
2015
Q3 | $36.3M | Buy |
|
|||||
|
2015
Q2 | $11.5M | Buy |
|
|||||
|
2015
Q1 | $3.12M | Buy |
|
|||||
|
2014
Q4 | $1.09M | Sell |
|
|||||
|
2014
Q3 | $2.62M | Sell |
|
|||||
|
2014
Q2 | $4.98M | Sell |
|
|||||
|
2014
Q1 | $7.85M | Buy |
|